文献速递临床试验与 GCP

宫腔镜子宫肌瘤切除术中程序化镇静镇痛与全身麻醉的比较(PROSECCO试验):一项多中心随机对照试验

Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial.
PubMed 文献 · PLoS Med · 2023-12-28

这项在荷兰14所大学和教学医院开展的多中心随机对照非劣效性试验,纳入209例有症状的0型或1型子宫肌瘤女性,比较丙泊酚程序化镇静镇痛(PSA)与全身麻醉(GA)下宫腔镜子宫肌瘤切除术。PSA组完全切除率87.8%(86/98)vs GA组88.8%(79/89),风险差-1.01%(95%CI -10.36至8.34),非劣效性检验P=0.09,未证明非劣效;但临床结局与生活质量无显著差异,PSA组住院更短。

要点

  • PSA组完全切除率87.8%(86/98)vs GA组88.8%(79/89),非劣效性未证明(P=0.09)。
  • 无严重麻醉并发症,无PSA转GA;随访期15例严重不良事件均为过夜住院且与研究干预无关。
  • 作者建议(弱推荐)0型或1型子宫肌瘤宫腔镜肌瘤切除术可在门诊PSA下进行。

核心结论

  • PSA在切除完整性方面未显示非劣效性,但临床结局与生活质量无显著差异。
  • 与GA相比,PSA下0型或1型子宫肌瘤宫腔镜肌瘤切除术安全且住院更短。
  • 作者建议(弱推荐)宫腔镜肌瘤切除术可在门诊PSA下进行。

研究设计与样本

  • 多中心、随机对照非劣效性试验,2016年至2021年在荷兰14所大学和教学医院开展。
  • 纳入年龄≥18岁、最多3个0型或1型肌瘤、最大肌瘤直径3.5 cm、美国麻醉医师协会分级1或2级、荷兰语或英语知识足够的女性。
  • 排除凝血障碍或严重贫血(Hb<5.0 mmol/L)者;采用区组随机化,区组大小2、4、6。
  • 共209例女性接受PSA(n=106)或GA(n=103)下宫腔镜肌瘤切除术;PSA组平均年龄45.1岁(SD 6.4)vs GA组45.0岁(SD 7.7)。
  • 主要结局为术后6周经阴道超声评估的完全切除百分比,由对治疗组和手术结局设盲的超声医师评估;随访1年。

主要发现

  • 主要结局分析:PSA组86/98例(87.8%)完全切除 vs GA组79/89例(88.8%),风险差-1.01%(95%CI -10.36至8.34),非劣效性P=0.09。
  • 未发生严重麻醉并发症,无需从PSA转为GA。
  • 随访期间发生15例严重不良事件(过夜住院),均与研究干预无关。

关键数值与推荐

  • 非劣效性界值为不完全切除的7.5%,采用Farrington-Manning检验。
  • 主要结局按意向性治疗原则分析,并包括符合方案分析。
  • PSA组98/106例、GA组89/103例有主要结局分析数据。

临床怎么用

  • 作者建议(弱推荐)0型或1型子宫肌瘤宫腔镜肌瘤切除术可在门诊PSA下进行。
  • 作者认为这些结果可用于妇科医生和麻醉科医生对患者进行咨询。

局限性

  • 主要局限性为主要结局的选择。
  • 研究证实把握度不足(underpowered)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hysteroscopic resection is the first-choice treatment for symptomatic type 0 and 1 fibroids. Traditionally, this was performed under general anesthesia. Over the last decade, surgical procedures are increasingly being performed in an outpatient setting under procedural sedation and analgesia. However, studies evaluating safety and effectiveness of hysteroscopic myomectomy under procedural sedation are lacking. This study aims to investigate whether hysteroscopic myomectomy under procedural sedation and analgesia with propofol is noninferior to hysteroscopic myomectomy under general anesthesia. METHODS AND FINDINGS: This was a multicenter, randomized controlled noninferiority trial conducted in 14 university and teaching hospitals in the Netherlands between 2016 and 2021. Inclusion criteria were age ≥18 years, maximum number of 3 type 0 or 1 fibroids, maximum fibroid diameter 3.5 cm, American Society of Anesthesiologists class 1 or 2, and having sufficient knowledge of the Dutch or English language. Women with clotting disorders or with severe anemia (Hb < 5.0 mmol/L) were excluded. Women were randomized using block randomization with variable block sizes of 2, 4, and 6, between hysteroscopic myomectomy under procedural sedation and analgesia (PSA) with propofol or under general anesthesia (GA). Primary outcome was the percentage of complete resections, assessed on transvaginal ultrasonography 6 weeks postoperatively by a sonographer blinded for the treatment arm and surgical outcome. Secondary outcomes were the surgeon's judgment of completeness of procedure, menstrual blood loss, uterine fibroid related and general quality of life, pain, recovery, hospitalization, complications, and surgical reinterventions. Follow-up period was 1 year. The risk difference between both treatment arms was estimated, and a Farrington-Manning test was used to determine the p-value for noninferiority (noninferiority margin 7.5% of incomplete resections). Data were analyzed according to the intention-to-treat principle, including a per-protocol analysis for the primary outcome. A total of 209 women participated in the study and underwent hysteroscopic myomectomy with PSA (n = 106) or GA (n = 103). Mean age was 45.1 [SD 6.4] years in the PSA group versus 45.0 [7.7] years in the GA group. For 98/106 women in the PSA group and 89/103 women in the GA group, data were available for analysis of the primary outcome. Hysteroscopic resection was complete in 86/98 women (87.8%) in the PSA group and 79/89 women (88.8%) in the GA group (risk difference -1.01%; 95% confidence interval (CI) -10.36 to 8.34; noninferiority, P = 0.09). No serious anesthesiologic complications occurred, and conversion from PSA to GA was not required. During the follow-up period, 15 serious adverse events occurred (overnight admissions). All were unrelated to the intervention studied. Main limitations were the choice of primary outcome and the fact that our study proved to be underpowered. CONCLUSIONS: Noninferiority of PSA for completeness of resection was not shown, though there were no significant differences in clinical outcomes and quality of life. In this study, hysteroscopic myomectomy for type 0 and 1 fibroids with PSA compared to GA was safe and led to shorter hospitalization. These results can be used for counseling patients by gynecologists and anesthesiologists. Based on these findings, we suggest that hysteroscopic myomectomies can be performed under PSA in an outpatient setting. TRIAL REGISTRATION: The study was registered prospectively in the Dutch Trial Register (NTR 5357; registration date: 11 August 2015; Date of initial participant enrollment: 18 February 2016).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. van der Meulen JF, Bongers MY, van der Zee LG, et al. Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial. PLoS Med. 2023. PMID: 38153958. doi:10.1371/journal.pmed.1004323

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。